TP53 and familial pancreatic carcinoma: ,23 Since KRAS∗ and combinations of mutation in p53 and p1624 may allow pancreatic cancer cells to bypass classical senescence pathways, targeting senescence pathways regulated by GOT2 may be important in overcoming therapeutic resistance in pancreatic cancer.